The severe guidance cut and BetterHelp decline signal accelerating deterioration in Teladoc's core business. Traders should monitor for potential securities litigation filings and any further downward revisions. The stock's 30% drop may not fully reflect the magnitude of the guidance cut if the market was surprised by the magnitude.
Price Chart
Executive Summary
Levi & Korsinsky announced an investigation into Teladoc Health following a 30% stock drop after Q2 2026 revenue of $606.9M missed expectations and full-year guidance was slashed from $2.48B-$2.57B to $2.36B-$2.45B, with BetterHelp projected to decline 19%-12.7%. The investigation focuses on potentially misleading statements about revenue and guidance.
Key Financial Metrics
Key Facts
- Q2 2026 consolidated revenue of $606.9 million, below consensus expectations
- Full-year revenue guidance cut from $2.48B-$2.57B to $2.36B-$2.45B
- BetterHelp division now projected to decline 19%-12.7% (previously 6.5%-1%)
- Stock fell nearly 30% in a single session after earnings release
- Levi & Korsinsky investigating potential materially false or misleading statements
Financial Impact
Revenue guidance lowered by $120M-$120M at midpoint; BetterHelp segment expected to decline up to 19% vs prior 1% decline
Risk Factors
- Further revenue guidance cuts if BetterHelp decline accelerates
- Securities class action litigation and associated costs
- Potential management credibility damage and investor distrust
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302840311 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 11, 2026 21d ago | 144 | $6.16 $6.30 | ▲ +2.27% | ▲ +2.49% | $5.52 (−10.39%) |
Sep 3, 2026 29d ago | Insider Cluster | $6.28 $6.50 | ▲ +3.50% | ▲ +4.71% | $5.52 (−12.10%) |
Sep 2, 2026 4w ago | 144 | $6.46 $6.09 | ▼ −5.73% | ▼ −4.77% | $5.52 (−14.55%) |
Aug 7, 2026 8w ago | Press Release | $7.13 $6.81 | ▲ +4.49% | ▲ +4.89% | $5.52 (+22.58%) |
Jul 31, 2026 9w ago | Press Release | $6.68 $7.08 | ▼ −5.99% | ▼ −3.96% | $5.52 (+17.37%) |
Jun 29, 2026 13w ago | 144 | $8.69 $9.29 | ▲ +6.90% | ▲ +5.52% | $5.52 (−36.48%) |
Jun 11, 2026 16w ago | 144 | $7.31 $7.59 | ▲ +3.83% | ▲ +3.40% | $5.52 (−24.49%) |
Jun 11, 2026 16w ago | Institutional Cluster | $7.31 $7.59 | ▲ +3.83% | ▲ +3.40% | $5.52 (−24.49%) |
Jun 2, 2026 17w ago | 144 | $7.09 $7.03 | ▼ −0.85% | ▲ +2.97% | $5.52 (−22.14%) |
Jun 2, 2026 17w ago | 144 | $7.09 $7.03 | ▼ −0.85% | ▲ +2.97% | $5.52 (−22.14%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access